Functional expression of opioid receptors and other human GPCRs in yeast engineered to produce human sterols | Nature Communications
SARS-CoV-2 Beta and Delta variants trigger Fc effector function with increased cross-reactivity - ScienceDirect
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination - ScienceDirect
Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies | Cell Discovery
Frontiers | Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies
The G protein-first activation mechanism of opioid receptors by Gi protein and agonists | QRB Discovery | Cambridge Core
Vaccines | Free Full-Text | The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far
Viruses | Free Full-Text | Genomic Epidemiology of the SARS-CoV-2 Epidemic in Cyprus from November 2020 to October 2021: The Passage of Waves of Alpha and Delta Variants of Concern
IJERPH | Free Full-Text | Shorter Incubation Period among Unvaccinated Delta Variant Coronavirus Disease 2019 Patients in Japan
Frontiers | SARS-CoV-2 Variants, Vaccines, and Host Immunity
SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern | PNAS
Molecules | Free Full-Text | Severe Acute Respiratory Syndrome Coronavirus-2 Inactivation Activity of the Polyphenol-Rich Tea Leaf Extract with Concentrated Theaflavins and Other Virucidal Catechins
Bacteria-enabled oral delivery of a replicon-based mRNA vaccine candidate protects against ancestral and delta variant SARS-CoV-2: Molecular Therapy
Emerging SARS-CoV-2 variants of concern and potential intervention approaches | Critical Care | Full Text
Kappa Delta Sorority - Gamma Kappa Chapter at UL Lafayette
Frontiers | The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape
IJMS | Free Full-Text | Syndecan-4 Is a Key Facilitator of the SARS-CoV-2 Delta Variant’s Superior Transmission
Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum | NEJM
Identification and differential usage of a host metalloproteinase entry pathway by SARS-CoV-2 Delta and Omicron - ScienceDirect
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Frontiers | Regulator of G-Protein Signaling (RGS) Protein Modulation of Opioid Receptor Signaling as a Potential Target for Pain Management
Interaction Analysis of the Spike Protein of Delta and Omicron Variants of SARS-CoV-2 with hACE2 and Eight Monoclonal Antibodies Using the Fragment Molecular Orbital Method | Journal of Chemical Information and Modeling
The antigenicity of SARS-CoV-2 Delta variants aggregated 10 high-frequency mutations in RBD has not changed sufficiently to replace the current vaccine strain | Signal Transduction and Targeted Therapy
